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Bri~ DeJinitive Report 
Phosphotyrosines in the Killer Cell Inhibitory Receptor 
Motif of NKB1 Are Required for Negative Signaling and for 
Assoc ia t ion  w i th  P ro te in  Tyros ine  Phosphamse 1C 
By Alicia M. Fry,~ Lewis L. Lani~rfl and Arthur Weiss*r 
From the *Department of Microbiology and Immunolog~ an# *Depanm~t ofMedidne, FIowa~ 
Hug4w~ Medical Institute University of California, San Frrmcisco, California 94143; 
and ~Department of Human Iramunology, DNAX Researeh Institute of M~mlar 
and Cellular Biolog~ Palo.,qfto~ Cntifornia 94304 
Summary  
NKB1 is one member o fa  ~owing family ofkiUer cell inhibitory receptms (K/R~. It is ex- 
pressed on natural kilIer (NK) cells and T cells, and has been showrt o inhibit cytolytic s 
tions of these cells upon interacting ~th  its hga~,, HLA-B (Bw4). We demongrate he_xe that 
the cytoplasmic' region of NKB1 is capab~ of inhibiting T cell, activation m jmrkat cdls. ~e  
ty~osme phosphorylation f the NKBI KtR consensus motif, YxxL(x)~YxxL, induces an amo- 
c/afion with the protein tyrosine phosphat~.se 1C (PTPIC). Im~rtantly, mutation of both ty- 
rosines in the motif a~ec l ,  the inhibitory functions of NKB1 and ahrt~ted PTIrtC 
tion. Mutational analysis of the individual tyrosines uggest hat the membrane pro.xim~ 
tyrosine may play a crtrdal role in mediating the inh/bitory signal. These results ~ ~  
that KIR can not only inhibit cytolytic activity, but can also negatively regulate T ceil receptor 
activation events that lead to downstream gene activation, and further supports a model that 
implicates PTP1C as a mediator in the K I~ inhibitory signal. 
"~r i l ler  cell inhibitory receptors (KIR), a growing hmiIy 
1~1,.of receptors that are present on NK cells and on sub- 
sets of peripheral T cells, inhibit cytolytic activi W by recog- 
nizing polymorphic MHC class I molecules on target cells 
(1). NK cells, important in innate immune respomes, rec- 
ognize and kill tumor cells, virus-infected cells, and cells 
lacking MHC class I antigens. The effector functions of 
NK cells, cytolytic activity and cytokine secretion, appear 
to be the result of a finely regulated balance between posi- 
tive signals that initiate the response and negative signals 
that inhibit the activated state (1). KIK appear to be impor- 
tant reguhtory molecules of NK cell effector functions. 
The KIR present on peripheral T cells also inhibit killing 
of target cells expresfmg art appropriate MHC class I ligand 
(2, 3). Although the positive signals through the antigen re- 
ceptor esulting in T cell activation are well defined (4), lit- 
de is known about the signals that may regulate the extent 
or degree o fT  cell activation. The presence of  KilL on T 
cells offers an intriguing candidate for a negative regulatory 
molecule of cytolytic and noncytolytic functions. 
The cytoplasmic tails of the KIR contain the consensus 
motif D/E(x)2YxxL(x)26YxxL (5--7), which is reminiscent 
of the irranunoreceptor tyrosine-based activation motif 
(ITAM) (D/E(x)2YxxL(x)7_sYxxL) present in TCtL and 
BCtL subunits (4). In T and B cells, the tyrosines (Y) in the 
I~TAM motif become phosplmcyhted atier receptor stim~ 
lation, and they mediate interaction with the Src homolog~f 
2 (SH2) domains of the ZAP-70/Syk ~ma-ly Oflma~em ty- 
rosine kinases fPTK; 8). The tymanes m the c~o~h~r 
region of the KIR nmy ~ be invoked in S/-12 im~ac- 
lions. Recerrdy, a study by Burshtyn et aL (9) showed ffrat 
the KIR p58 can bind to the protein tyrosine phospbatase 
1C (PTP1C). PTP1C (SHP-1, HCP, SH-PTPI) is ~ 66- 
kD protein and a member of  the cytoplasmic, SH2 dome-  
containing family of phosphahas~ which im:ludes PTPID 
(SHP-2, Syp, SH-PTP2) and the Dmsold~ protein r  
screw (10). PTP1C has. been shown to become induc i~ 
associated with the erythropoietin receptor (F4x)P~,, 
Fc'~IIB1, CD22, c-k/t, and the ILL-3 receptor I~ chain as 
stimulation of these receptors (I1-15). Recent stud/es, cor- 
relate the binding of PTPt C with the negative regt~tior~ 
of  the EpoR and the negative reguhtion ~R- r r te~a~ed 
activation by Fc~/RIIB1 (11, 12). Additionally, mutations 
in the PTP1C gene have been linked to the severe he- 
matopoietic defects in motheaten (me) and motheaten via- 
ble (mev) mice (16-Ig). 
In this report, we study the inhibito~ fnnctmn of the 
KIR NKBI m T cells. Transient ~ o n  os a CD8t 
NKB1 chimera in lurk, at T ce~ attowed analyses of the 
structural requirements of NKBI necessary for the inhibi- 
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tion of  TCR activation. We demonstrate hat the cytoplas- 
mic region of  NKB1 inhibited TClL-mediated down- 
stream gene activation in Jurkat T cells, and that tyrosine 
phosphorylation of NKB1 induced an association between 
PTP1C and the chimeric receptor. Also, mutational analy- 
sis of  the tyrosines in the K IR  consensus motif established 
the requirement of  phosphotyrosines for the inhibitory 
functions of  NKB1 and for association with PTP1C. 
Materials and Methods 
Cells. Jurkat cells and Raji cells were maintained in RPMI 
1640 medium supplemented with 5% FCS, penicillin, streptomy- 
cin, and glutamine, as previously described (19). 
Plasmids. The CD8/T construct was described previously 
(19). The CD8/NKB1 plasmid was made by digesting CD8/T 
with BgllI and BamH1 and ligating in a cytoplasmic fragment of 
NKB1 (basepairs 1114-1865), in which these enzyme sites were 
introduced by PCR mutagenesis or through shuttle vectors. A 
BgllI site was created at amino acid (aa) 364/365 (C/R mutation) 
in NKB1. Primers 5' and 3' of the Bsu36 and Espl sites, respec- 
tively, which mutated Y to F, were used to make the F1, F2, and 
FIF2 constructs. A primer 5' of the Bsu36 site, deleting 18 aa be- 
tween the two Y in the KIR motif, was used to create the 18-aa 
del construct. All constructs were sequenced using the Sanger 
dideoxy-nucleotide technique and then subcloned into the ex- 
pression vector pEF Bos. The NFAT-luciferase reporter con- 
struct was a generous gift from Dr. G. Crabtree (Stanford Univer- 
sity, Stanford, CA). 
Transfections, Stimulations, and NFA T-Luciferase assays. 107 Jur- 
kat cells were transfected by electroporation, aspreviously de- 
scribed (20), with 20/~g of the NFAT reporter plasmid and 40 
~g of the CD8 chimeric plasmids. 24-40 h after transfection, 2 • 
105 cells were aliquoted into 96-well plates (Coming Glassware, 
Coming, NY) and cultured in a final volume of 90 ~1. The re- 
maining cells were analyzed by flow cytometry for CD8 surface 
expression. For stimulation, equal numbers of Raji cells and Strep- 
tococcus enterotoxin D (SED; Toxin Technology Inc., Sarasota, 
FL) in the concentrations i dicated were added to each well. As a 
control for NFAT activation, cells were stimulated with 50 ng/ 
nO PMA and 1.0 I~M ionomycin. The average value of the PMA 
and ionomycin stimulation was used as a maximum stimulation 
value. After 6-8 h at 37~ cells were lysed and luciferase activa- 
tion was determined as described previously (20). Activation for 
each condition was determined in duplicate, and each experiment 
was repeated at least three times. The percent maximum stimula- 
tion value achieved with 300 ng/ml SED plus Raji was averaged 
from three independent experiments for each plasmid. 
Antibodies and Flow Cytometry. 4G10, an antiphosphotyrosine 
mAb, was purchased from Upstate Biotechnology, Inc. (Lake Placid, 
NY). Anti-PTP1C is a rabbit anti-mouse serum (generously pro- 
vided by Dr. J. Schlessinger, New York University, New York). 
OKT8 mAb recognizes an extracellular epitope of CD8 and was 
acquired from American Type Culture Collection (Rockville, 
MD). Anti-Zap-70 mAb has been described previously (21). FITC- 
conjugated mouse anti-Leu2a (anti-CD8) and FITC-conjugated 
mouse IgG1 were purchased from Becton Dickinson & Co. (Moun- 
tain View, CA). For flow cytometry, 5 • 105 to 106 cells were 
stained with saturating concentrations of antibody and then ana- 
lyzed using a FACScan | (Becton Dickinson), as previously de- 
scribed (22). 
Peptides and Peptide-binding Assays. The peptides were synthe- 
sized in a peptide synthesizer (Applied Biosystems, Inc., Foster 
City, CA), as previously described (21). The peptide sequence is: 
DPQEVT(Y) ITQLNHCVFTQRKITRPSQRPKTPPTDIIVCY) 
2TELPNAESR. Peptides were phosphorylated as follows: P1 
peptide on Y1; P2 peptide on Y2; P1P2 peptide on Y1 and Y2. 
P0 was unphosphorylated. The { peptides are described elsewhere 
(21). Peptide precipitation was performed with avidin-conjugated 
beads (Vector Laboratories, Burlingame, CA), as previously de- 
scribed (21). Methods for [3SS]methionine biosynthetic labeling 
were described previously (23). 
Western Blotting and Immunoprecipitation. 2 • 107 Jurkat cells 
were transiently transfected with 40 ~g of the CD8/NKB1 or 20 
~g of the FIF2 (plus 20 Ixg pEF Bos with no insert). 24-40 h 
later, 106 cells were analyzed by flow cytometry for surface CD8 
expression, and the remaining cells were stimulated with pervan- 
adate (10 mM Na-orthovanadate, 3.36% H202) for 10 rain at 
37~ The cells were then lysed in buffer containing 1% NP-40, 
10 mM Tris (pH 7.8), 150 mM NaC1, 2 mM EDTA, and pro- 
tease and phosphatase inhibitors, as previously described (20). Ly- 
sates were immunoprecipitated with 2 ~10KT8 ascites or 4 ~1 
anti-PTP1C serum and protein G-Sepharose (Pharmacia, Alameda, 
CA). The precipitates were separated by SDS-PAGE and trans- 
ferred to Immobilon-P membranes (Millipore, Bedford, MA). The 
blots were blocked, as described previously (20) and then incubated 
with primary antibody, followed by secondary step reagent con- 
jugated with horseradish peroxidase (protein A-HRP; Amersham, 
Arlington Heights, IL) or goat anti-mouse IgG-HRP (Southern 
Biotechnology Associates, Birmingham, AL). Proteins were de- 
tected by enhanced chemiluminescence (ECL kit; Amersham). 
Results and Discussion 
PTPI C-1 Associates with Doubly Tyrosine-phosphorTlated KIR 
Peptides. To identify proteins associated with the cyto- 
plasmic region of  the K IR  that may be involved in signal 
transduction, we generated biotinylated peptides correspond- 
ing to the K IR  consensus motif  of  NKAT1 (aa 295-341 
[5]) and used these peptides to precipitate proteins from 
metabolically labeled ceils. The peptides were either un- 
phosphorylated (P0) or, phosphorylated on the first (mem- 
brane proximal) (P1), the second (carboxy-terminal) (P2), 
or both tyrosines (P1P2). Only the P lP2 peptide was 
found to bind to a distinct 66-kD band in 3SS-metabolicaily 
labeled lysates from Jurkat ceils (data not shown). Western 
blot analyses using antisera against known SH2 domain- 
containing proteins in this molecular mass range identified 
PTP1C as one 66-kD protein that could bind to the dou- 
bly phosphorylated peptide (Fig. 1). The P1P2 peptide 
bound to PTP1C in a dose-dependent manner. Conversely, 
the doubly phosphorylated ~ peptide bound to ZAP-70, 
but not to PTP1C, confirming the specificity of  the inter- 
action. Phosphorylation of both tyrosines was required for 
in vitro binding, since the single phosphotyrosine p ptides 
did not bind to PTP1C. Therefore, PTP1C associated with 
the doubly tyrosine phosphorylated K IR  peptide but not to 
the unphosphorylated or singly tyrosine phosphorylated 
peptides. 
These peptide binding study results differ from those by 
Burshtyn et al., who showed PTP1C association with sin- 
gle phosphotyrosine peptides (9). This may represent dif- 
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Figure 1. Binding of PTPIC to phosphorylated KIP, peptides. Total 
cell lysates from unstimulated Jurkat cells were mixed with the indicated 
biotinylated peptides, p~ is a doubly tyrosine-phosphorylated ~ITAM pep- 
tide. ~ is an unphosphorylated ~ITAM peptide. The ~ peptides are described 
elsewhere (21). The remaining peptides are based on the NKAT1 KIP. 
motif, DPQEVT(Y) 1TQLNHCVFTQP`KITP`PSQP`PKTPPTDIIV- 
(Y)2TELPNAESP`. P0 is unphosphorylated. P1, P2, and P1P2 are phos- 
phorylated on the first, second, and both tyrosines, respectively. The 
amount of peptide is given in micrograms. Peptides were isolated with 
avidin-conjugated beads, and the complexes were analyzed byimmuno- 
blot analysis with the antibodies shown n the left. Lysates from 4.5 • 
107 cells were used for each peptide and samples were split and loaded on 
two separate gels. Whole-cell lysate (WCL) on the left is a positive con- 
trol for the protein detected by the antibody. Avidin-conjugated beads 
(BEADS) with no peptide is shown on the fight. 
ferences in the peptide-binding assays. For example, Bursh- 
tyn et al. used peptides covalendy conjugated to Affi-gel 10 
containing only a partial KIP,. p58 consensus motif. The 
high local concentration of  the phosphorylated peptide 
bound to Am-gel  10 may have facilitated etection of  the 
interaction and involved both SH2 domains binding to 
multiple peptides. However,  the solution binding studies 
reported here show that a high affinity interaction is fa- 
vored when both tyrosines of  a single KIP, peptide are 
phosphorylated. 
PTP1C Associates with the Cytoplasmic Region of NKB1. 
To further study the mechanisms by which NKB1 medi-  
ates negative signaling in T cells and whether this involves 
PTP IC  binding, we constructed a CD8/NKB1 chimeric 
expression vector. This construct, ontaining the extracel- 
lular and transmembrane r gion of  the CD8 molecule and 
the intracellular egion of  NKB1, was transiently trans- 
fected into Jurkat T cells. We also mutated the first (F1), 
the second (F2), or both tyrosines to phenylalanine (F1F2) 
in the K IR  consensus moti f  of  NKBI  (Fig. 2 A) and trans- 
fected these into Jurkat cells. 
The transfected cells were stimulated with pervanadate, a 
phosphatase inhibitor that induces maximal tyrosine phos- 
phorylation (24), lysed, and the CD8/NKB1 chimera pro- 
teins precipitated. The CD8/NKB1 proteins were resolved 
by SDS-PAGE and blotted with ant i -PTPIC.  As shown in 
Fig. 2 B (upper panel), PTP IC  associated with the CD8/  
NKB1 chimera expressed in Jurkat T cells after tyrosine 
phosphorylation of NKB1 by pervanadate. Despite a higher 
expression level, the mutant lacking both tyrosines (F1F2), 
did not associate with PTP1C. Stripping and reblotting the 
wild-type CD8/NKB1 chimera protein with an antiphos- 
photyrosine mAb 4G10 demonstrated a 40-kD phosphory- 
Figure 2. PTP1C binds to the phosphorylated CD8/NKB1 chimera. 
(A) Amino acid sequence of the cytoplasmic region of NKB1 highlight- 
ing tyrosines in the KIP. motif that were mutated. F1 mutated the first Y 
to F, F2 the second, Y and FIF2 mutated both. 18-aa del deleted 18 
amino acids between the two tyrosines. (B) Jurkat T cells were transfected 
with plasmids encoding CD8/NKB1 or the F1F2 mutant. 40 h after 
transfection, cells were l ft either unstimulated or stimulated with pervana- 
date for 10 min and then lysed. The lysates were immunoprecipitated 
with anti-CD8 (OKTS) and blotted with anti-PTP1C (upperpane O. The 
blot was then stripped and reblotted with antiphosphotyrosine mAb 
(4GIO; lower panel). The arrow corresponds to the chimera. Each lane 
represents 4.5 • 107 cells. CD8 surface expression for CD8/NKB1 and 
F1F2 were 5 and 41% positive cells, respectively. Whole-cell lysates 
(WCL) representing 106 cells are shown o the fight. Similar results with
equivalent tyrosine phosphorylation patterns were seen in th e other x- 
periments. 
lated protein in the pervanadate-stimulated cell lysate, con- 
sistent with the migration of the chimera protein (Fig. 2 B, 
lower panel). Similarly, the CD8/NKB1 chimera was de- 
tected in PTP1C immunoprecipitates (data not shown). 
Therefore, the phosphotyrosines in the KIP, motif  of  NKB1 
are necessary for PTP1C association. These results are con- 
sistent with the in vitro peptide-binding studies presented 
above, 
The Cytoplasmic Domain of NKB1 Is Capable of Inhibiting 
TCR Activation. The in vivo transient expression system 
described above also allowed us to assess the functional ef- 
fect of  NKB1 expression on TCR.-mediated signal trans- 
duction. Activation through the TCR was achieved by 
stimulation with the superantigen, SED, presented by the 
Raji  B cell line, and was monitored by transcriptional cti- 
vation of  the NFAT-luciferase reporter. As shown in Fig. 3 
A, we observed a striking inhibition in NFAT activation in 
T cells expressing the chimera containing NKB1 when 
compared to a truncated CD8 molecule (CD8/T).  Thus, 
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the cytoplasmic region of  NKB1 is sufficient to inhibit 
TCR-mediated downstream gene activation in Jurkat T 
cells. NKB1 has also bee** implicated in the negative regu- 
lation of  IFN-~/and TNF-a  product/o** in NKB1 + T cell 
clones (25). Therefore, NKB1 appears to regulate both cy- 
tolytic and nonqm~ytic effector functions in T ceils. 
Inhibition by Nt~t  Is Me~'ated by the Tyrosines in the KIR 
Consensus Motif. To further study the structural impor- 
tance o f  phosphotyrosines in the inhibitory signal of  
NKB1, we transiendy expressed the tyrosine mutant con- 
structs (Fig. 2 A) and assessed their ability to inhibit TCg-  
mediated NFAT activat~or,. The mutation of  both ty- 
rosmes (F1F2) completely abolished the mhl~dtory effect of  
NKB1 (Fig. 3 B). This effect was not ca~tsed by expression 
levels because the F1F2 mutant was present at much higher 
levels than the CD8/NKBi  chimera, based on flow cy-  
tometry atmtysis. Therefore, loss of iahibit ion must be a con- 
sequence of  the tyrosme matatioas. The 1ms ofinkibit ion by 
the F1F2 mutam correlates with the ahse~e of  PTP1C as- 
sociation demonstrated in Fig. 2. Therefore, PTP1C is likely 
to be important in mediating the inhibitory signal of  the 
NKB1 KIR. 
Subsequent analysis of  the single tyrosine mutants, FI 
and F2, suggest hat the tyrosines may have different de- 
grees of  impoct~ce in the mhibitea-y signal mediated by 
NKBI .  The F2 rmitant inhibited NFAT act iwt ion to a 
simitar degree as the wild-type CD~NKBI  dmrg'ra, whereas 
the F1 nmtam ~ it to a m~ch Jesser extent (~--~5~A 
OfCD8/NKB1) .  Th~ both tyrosines omatrib~e to the in- 
hibitory effect, ~ut ttte first tyromae (mem~a~e t~roximal) 
appears crtacial. Interestingly, B~tsht~ et ,1. (9) found a 
greater ~ t  OfPTP1 C,mzyme ac0vi~ with a phos-- 
phorytated i~eptide containing the fiu, t qrrosine [pY1) from 
the K IR  mot i f  dam wirk a peptide contmmng the second 
tyrosine (pY2). The difference in inhibition between F1 
and F2 detected in our in vivo assay may reflect either dif- 
ferential binding to PTP1 C or differences in phosphatase 
activation. 
The K IR  consensus mot i f  is very similar to the ITAM 
motif  present in TCR and BCR subunits. The two ty- 
rosines in the ITAM moti f  are important for ZAP-70/Syk 
binding (8). In the crystal structure of  ZAP-70 bound to a 
phosphorytatext peptide, the SH2 domains are in a fixed 
position and oriented in such a way as to place strict spatial 
constraints on the spacing between tyrosines in the ITAM 
(26). We tested whether the tyrosines in the K IR  moti f  
Figure 3. Inhibition of superantigen-induced Jurkat activation by the 
CD8/NKBI chimera is dependent on cytoplasmic tyrosines. (A)Jurkat T 
cells were cotramFected with plasmids encoding CD8/T orCD8/NKBI 
and NFAT-luciferase. Transfected cells were stimulated with equal num- 
bers of Raji cells plus SED at the concentrations indicated and then as- 
sayed for luciferase activity. The results are shown as the percent ofPMA 
plus ionomycin mmulation. PMA #us ionomycin values for CD8/T and 
CD8/NKBI were 40,602, and 120,675 light units,respectively. CD8 
surface xpre~on leve~ for CD8/T and CD8/NKB1 were 25 and 12% 
positive cells, respectively. --~3-, CD8/T; + ,  CD8/NKB.1. (B)Jur- 
kat T cells were cotransfected with NFAT-luciferase and plasmids encod- 
ing CD8/T, CD8/NKB1, FI, F2, F1F2, and 18-aa del. Transfected cells 
were then stimulated with R.aji cells and SED i  the concentrations ira]i- 
cared and assayed for luciferase activity. The results are shown as percent 
of PMA plus ionomycin stimulation. PMA plusionomycin values for 
CD8/T, CD8/NKB1, F1, F2, FIF2, and 18-aa del were 78,358, 116,664, 
141,725, 131,383, 79,636, and 78,840 light units, respectively. The p r- 
cent of CD8--positive c lls were: CD8/T, 33%; CDS/NKB1, 9~ F1, 33%; 
F2, 22%; FIF2, 30~ and 18-aa del, 23%. Vector without insert gave lu- 
ciferase activity that was 25--50~ higher than CD8/T. ~ ,  CD8/T; 
--O--, CD8/NKB.1; -~--, F1; --~-, F2; --{~--, F1F2; - "O- -, 18-aa del. 
A a d B each represent individual experiments. (C) The results are ex- 
pressed as the mean ma.xamum sttmulation from three independent exper- 
ments (300 ng/ml SED). Error bars represent SD fi'om the mean. 
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were also spaced at a stericaUy important distance, We de- 
leted 18 amino acids between the two tyrosines in the 
NKB1 KIR motif  (Fig. 2 A) and tested the mutant for its 
abihty to inhibit TCR-mediated NFAT activation. As Fig. 
3 B demonstrates, the expression of  this mutant (18-aa del) 
inhibited NFAT activation to the same degree as the wild- 
type CD8/NKB1 chimera. Thus, altering the spacing be- 
tween tyrosines did not affect the inhibitory effect ofNKB1, 
suggesting that the spacing is not essential in the protein in- 
teractions that mediate inhibition. The crystal structure of  
the SH2 domains of  the related PTP PTP1D bound to 
phosphotyrosine peptides may offer an explanation for 
these findings. The SH2 domains of  PTP ID  are fixed in 
orientation, like the ZAP-70 SH2 domains, but in contrast 
to ZAP-70, they are oriented such that the phosphoty- 
rosine peptides are roughly antiparalleI relative to each 
other (27). This suggests that the binding of  the SH2 do- 
mains of  PTP ID  and related phosphatases like PTP IC  to 
phosphotyrosines may not occur in tandem, like ZAP-70, 
but on two separate proteins in trans. Thus, alteration of  
the spacing between the two tyrosines in the KIR motif 
might not affect PTP IC  binding. 
In summary, we demonstrate that expression of  the cy- 
toplasmic domain of  the K IR  NKB1 in a chimeric receptor 
inhibits TCK-mediated ownstream gene activation in Jur- 
kat T cells. Tyrosine phosphorylation of  the NKB1 chi- 
mera in Jurkat cells induced association between PTP1C 
and the chimeric receptor. Mutations of  both tyrosines 
abolished the ability of  NKB1 to both inhibit TCR activa- 
tion and to bind PTP1C. The in vitro peptide-binding 
studies suggest hat optimal binding of  PTP1C to the KItK 
motif occurs when both tyrosines are phosphorylated. How- 
ever, the single tyrosine mutants (F1 or F2) retained their 
ability to inhibit TCK activation, suggesting that PTP1C 
association with KI1K proteins may occur in cis or trans. 
The membrane-proximal tyrosine plays a crucial role in 
mediating the inhibitory signal. In contrast o the tyrosine 
mutations, alteration of  the spacing between tyrosines in 
the KIP, consensus motif did not affect the inhibitory sig- 
nal. These results support a model in which PTP1C plays a 
role in mediating the negative signal transmitted by NKB1 
and are consistent with studies by Burshtyn et al. (9). Fu- 
ture studies on the targets of  NKB1 will further clarify its 
role in modulating TCR-mediated signals. 
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